Literature DB >> 3721983

Prognostic factors for multiple myeloma in the dog.

R E Matus, C E Leifer, E G MacEwen, A I Hurvitz.   

Abstract

Multiple myeloma was diagnosed in 60 dogs. Diagnosis was confirmed in each case by observation of greater than 5% plasma cells on examination of a bone marrow aspirate and detection of monoclonal gammopathy of immunoglobulin (Ig) A or IgG. Treatment with melphalan, cyclophosphamide, and prednisone was associated with long-term survival (median, 540 days). Response to therapy was significantly related to prognosis (P less than 0.01), whereas hypercalcemia and Ig light chain proteinuria (Bence Jones) were associated with shorter median survival times.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721983

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  15 in total

1.  Monoclonal gammopathy associated with multiple myeloma and visceral leishmaniasis in the dog: a comparison of two cases.

Authors:  M T Antognoni; F Birettoni; A Miglio; P Lalli; F Porciello; V Mangili Pecci
Journal:  Vet Res Commun       Date:  2010-06       Impact factor: 2.459

2.  Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide.

Authors:  J H Burton; H K Knych; S D Stanley; R B Rebhun
Journal:  Vet Comp Oncol       Date:  2017-01-25       Impact factor: 2.613

3.  Solitary osseous plasmacytomas in dogs: 13 cases (2004-2019).

Authors:  A J Reising; L L Donnelly; B K Flesner; C A Maitz; J N Bryan
Journal:  J Small Anim Pract       Date:  2021-08-31       Impact factor: 1.669

4.  Immunoglobulin A multiple myeloma with cutaneous involvement in a dog.

Authors:  Monique N Mayer; Moira E Kerr; Candace K Grier; Valerie S Macdonald
Journal:  Can Vet J       Date:  2008-07       Impact factor: 1.008

5.  Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs.

Authors:  Ricardo Fernández; Esther Chon
Journal:  J Vet Intern Med       Date:  2018-03-22       Impact factor: 3.333

Review 6.  Review of oncological emergencies in small animal patients.

Authors:  Katrina L Tumielewicz; Danielle Hudak; Jennifer Kim; David W Hunley; Lisa A Murphy
Journal:  Vet Med Sci       Date:  2019-03-21

7.  Multiple myeloma and primary erythrocytosis in a dog.

Authors:  Marianna Ricci; Giulia De Feo; Martin Konar; George Lubas
Journal:  Can Vet J       Date:  2021-08       Impact factor: 1.008

8.  GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.

Authors:  Douglas H Thamm; David M Vail; Ilene D Kurzman; Darius Babusis; Adrian S Ray; Noel Sousa-Powers; Daniel B Tumas
Journal:  BMC Vet Res       Date:  2014-01-25       Impact factor: 2.741

Review 9.  Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Gionata De Vico; Tommaso Iannitti
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

Review 10.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.